Table of Contents Table of Contents
Previous Page  81 / 244 Next Page
Information
Show Menu
Previous Page 81 / 244 Next Page
Page Background

OL10-5

The role of irisin in components of metabolic syndrome,

insulin secretion and resistance in schoolchildren

Chung-Ze WU

1,2

, Jin-Shuen CHEN

3

, Li-Chien CHANG

4

,

Yuh-Feng LIN

5,6

, Dee PEI

7

, Nain-Feng CHU

8,9

.

1

Division of

Endocrinology and Metabolism, Department of Internal Medicine,

Shuang Ho Hospital, Taipei Medical University,

2

Department of

Internal Medicine, School of Medicine, College of Medicine, Taipei

Medical University,

3

Division of Nephrology, Department of Internal

Medicine, Tri-service, General Hospital, National Defense Medical

Center,

4

National Defense Medical Center, School of Pharmacy,

5

Graduate Institute of Clinical Medicine, College of Medicine, Taipei

Medical University,

6

Department of Internal Medicine, Shuang Ho

Hospital, Taipei Medical University,

7

School of Medicine, College of

Medicine, Fu Jen Catholic University,

8

Superintendent, Taitung

Hospital, Ministry of Health and Welfare,

9

National Defense Medical

Center, School of Public Health, Taiwan

Background:

The prevalence of obesity worldwide has

increased rapidly in recent decades, leading to increased

morbidities and mortalities. Different from white adipose

tissue, brown and beige adipose tissues contain abundant

mitochondria, and help burn energy and create non-shivering

thermogenesis. Enriching brown and beige adipose tissue may

have potential as an anti-obesity strategy. Irisin, shaved from

fibronectin type III domain containing 5 (FNDC5) in muscle

tissue, increases after exercise and is believed to be the

crucial factor in converting white adipose tissue to beige

adipose tissue. In the present study, we explored the relation-

ship between irisin levels and components of metabolic

syndrome, fibrinolytic proteins, insulin secretion and resist-

ance in schoolchildren in Taiwan.

Methods:

Therewere 369 children (172 boys and 197 girls), aged

10.3 ± 1.5 years, enrolled from Taiwan elementary schools in

our study. Irisin, anthropometry, metabolic syndrome compo-

nents, insulin secretion, and resistance were measured.

Subjects were divided into normal, overweight, and obese

groups for evaluation of irisin in obesity. Finally, the relation-

ship between irisin level and metabolic syndrome in boys and

girls was analyzed.

Results:

In boys, irisin levels were not associated with BMI

percentile, body fat, blood pressure, lipid profiles, insulin

secretion or resistance. The irisin levels in boys were asso-

ciated, however, with age and fasting plasma glucose. After

adjusting for age, the irisin level in boys was negatively related

to fasting plasma glucose (r =

0.21, p = 0.006) and weakly

positively related to soluble plasma activator receptors (r =

0.135, p = 0.046). In girls, the irisin levels were associated with

age and body fat. However, after adjusting of age, the irisin

levels in girls were only positively related to fasting plasma

glucose (r = 1.49, p = 0.038). In both genders, irisin levels were

similar among normal, overweight, and obese groups, and

between subjects with and without metabolic syndrome.

Conclusion:

The irisin levels were not associated with meta-

bolic syndrome and obesity in either boys or girls in Taiwan.

However, we found that the irisin levelswere negatively related

to fasting plasma glucose in boys and positively related to

fasting plasma glucose in girls. The contrary relationship

between irisin and fasting plasma glucose in boys and girls

needs further exploration in the future.

OL10-6

Association between 1,5-anhydroglucitol and early-phase

insulin secretion in Chinese patients with newly diagnosed

type 2 diabetes mellitus

Jian ZHOU

1

, Xiaojing MA

1

, Hang SU

1

, Yaping HAO

1

, Xiang HU

1

,

Yuqi LUO

1

, Zixuan DENG

1

, Yuqian BAO

1

, Weiping JIA

1

.

1

Department of Endocrinology and Metabolism, Shanghai Jiao Tong

University Affiliated Sixth People

s Hospital, Shanghai Clinical Center

for Diabetes, Shanghai Diabetes Institute, Shanghai, China

Objective:

Glucose monitoring plays a key role in comprehen-

sive management of diabetes. Insulin secretion deficiency and

insulin resistance are involved in both the onset and progres-

sion of diabetes mellitus. The goal of this study was to probe

into the relationships of glycated hemoglobin A1c (HbA1c) and

1,5-anhydroglucitol (1,5-AG) with insulin sensitivity and

secretion in patients who were newly diagnosed with type 2

diabetes mellitus.

Methods:

A total of 302 patients with newly diagnosed type 2

diabetes mellitus (166 men and 136 women; age range, 27

79

years old) were enrolled in this study. The homeostasis model

assessment of insulin resistance (HOMA-IR) and homeostasis

model assessment of

β

cell function (HOMA-

β

) were calculated

to evaluate the basal insulin sensitivity and secretory function,

respectively. Insulinogenic index (IGI) was used for assess-

ment of early-phase insulin secretion. HbA1c was detected by

high-performance liquid chromatography. Serum 1,5-AG was

assayed using the enzymatic method.

Results:

When the subjects were stratified according to HbA1c

quartiles, the trends analyses showed an upward trend

for HOMA-IR and downward trends for both HOMA-

β

and IGI

with increasing HbA1c quartiles (all P for trend <0.001).

Increased 1,5-AG quartiles were accompanied by a decreasing

trend in HOMA-IR and increasing trends in HOMA-

β

and IGI

(all P for trend <0.001). Multiple stepwise regression analysis

revealed that the independent correlations of HOMA-IR

(standardized

β

= 0.525) and HOMA-

β

(standardized

β

=

0.673)

with HbA1c were present (both P < 0.001) when HbA1c was

defined as the dependent variable. Moreover, 1,5-AG was not

only independently associated with HOMA-IR and HOMA-

β

(standardized

β

=

0.349 and 0.232, both P < 0.01), but also

exhibited an independent and positive association with IGI

(standardized

β

= 0.242, P < 0.001).

Conclusions:

1,5-AG level was not only correlated with basal

insulin sensitivity and secretion, but also closely associated

with early-phase insulin secretion in Chinese patients with

newly diagnosed type 2 diabetes mellitus.

OL10-7

Increases in urinary N-acetyl-

β

-D-glucosaminidase excretion

are associated with increased arterial thickness and presence

of carotid plaques in type 2 diabetes

So Ra KIM

1

, Gyuri KIM

1

, Ji-Yeon LEE

1

, Yong-ho LEE

1

,

Eun Seok KANG

1

, Bong-Soo CHA

1

, Byung-Wan LEE

1

*.

1

Department of Internal Medicine, Yonsei University College of

Medicine, Seoul, Korea

N-acetyl-

β

-D-glucosaminidase (NAG) present in high concen-

tration in lysosomes of proximal renal tubular cells is released

into the urine after renal proximal tubule injury. Recently,

urinary NAG has gained considerable attention because of its

clinical implications as a sensitive and specific biomarker

for early stage diabetic kidney disease. Several studies on

associations between urinary NAG and micro-/macrovascular

complications of diabetes have been reported. However, there

is no data on association between urinary NAG and carotid

intima media thickness (IMT) in patients with type 2 diabetes

mellitus (T2D). The aim of this study was to investigate

whether increases in urinary NAG are associated with arterial

atherosclerosis assessed by carotid IMT. In this retrospective

cross-sectional study, a total of 343 participants with T2D

who had been tested for urinary NAG, carotid IMT, and

gluco-metabolic parameters were enrolled. Demographic

factors including age, sex, body mass index, smoking habit,

blood pressure, duration of diabetes, and history of cardiovas-

cular events were recorded. Mean age and duration of diabetes

were 59.9 and 11.6 years, respectively. The participants with

above median level of urinary NAG (11.4 (8.72

16.7) U/gCr)

showed significantly higher values of mean and maximum

carotid IMT (0.72 (0.60

0.84) vs 0.67 (0.58

0.77) mm and 0.90

(0.74

1.06) vs 0.82 (0.70

0.97) mm, respectively) than

Oral Presentations / Diabetes Research and Clinical Practice 120S1 (2016) S40

S64

S63